UCLA Hematology/Oncology - Santa Monica — Los Angeles, California

UCLA Hematology/Oncology - Santa Monica is a clinical research site located in Los Angeles, California, United States 90404.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

UCLA Hematology/Oncology - Santa Monica has participated in 8 clinical trials with 8 currently active.

Therapeutic areas: Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM), Carcinoma, Non-Small-Cell Lung.

Sponsors: Pfizer, Juno Therapeutics, Inc., a Bristol-Myers Squibb Company, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Hematology/Oncology - Santa Monica?

UCLA Hematology/Oncology - Santa Monica has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Hematology/Oncology - Santa Monica conducted?

UCLA Hematology/Oncology - Santa Monica has 8 clinical trials on record, with 8 currently active. Their work covers Multiple Myeloma, Relapsed or Refractory Multiple Myeloma (RRMM), Carcinoma, Non-Small-Cell Lung.

Is UCLA Hematology/Oncology - Santa Monica accredited by Crixeo Health?

Yes — UCLA Hematology/Oncology - Santa Monica holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UCLA Hematology/Oncology - Santa Monica?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.